Company Overview and News
In early February, the stock market was in sell-off mode because inflation and rate hikes were pushing up fixed income yields, which was increasing borrowing costs and pressuring equity valuations.
JD FB SHOP NFLX GOOG NVDA CRM ADBE WB BABA AMZN IQ AAPL BIDU
General Electric (NYSE:GE) and Microsoft (NASDAQ:MSFT) reported earnings and reacted in very different ways. Tesla (NASDAQ:TSLA) could be gearing up for a big move, too. Here are our top stock trades for Monday:
GE F GEC GM.WS.A GM.WS.B GM.WS.C TSLA GNE MSFT GM GM.WSB ADBE
Intuit (INTU - Free Report) recently announced that it is selling its largest data center based in Quincy, WA to H5 Data Centers, a privately-owned data center operator in the country. The move resonates with the company’s strategy to shift all services to public cloud instead of investing in owning hosting platforms. By the end of tax season, all its TurboTax online users were served from Amazon (AMZN - Free Report) Web Services, per management.
INTU VRNT KDP ADBE
Microsoft Corporation (MSFT - Free Report) reported fourth-quarter fiscal 2018 earnings of $1.13 per share, beating the Zacks Consensus Estimate by six cents. The figure increased 6.6% on a year-over-year basis. Revenues of $30.09 billion increased 17.5% from the year-ago quarter (up 13% in constant currency or cc). Further, the figure exceeded the Zacks Consensus Estimate of $29.21 billion. Commercial bookings surged 18% (same at cc).
VRNT KDP MSFT ADBE WMT
Chicago, IL – July 20, 2018 - Stocks in this week’s article Mellanox Technologies Ltd. (MLNX - Free Report) , Microchip Technology Inc. (MCHP - Free Report) , ConocoPhillips (COP - Free Report) and Adobe Systems Inc. (ADBE - Free Report) .
COP WLL KDP MLNX MCHP ADBE
SAP SE (SAP - Free Report) reported second-quarter 2018 non-IFRS earnings of €0.98 ($1.17) per share, up 4.3% on a year-over-year basis. However, the bottom line fell short of the Zacks Consensus Estimate of $1.18 per share. On IFRS basis, earnings of €0.60 (71 cents) per share increased 7.1% on a year-over-year basis. Total revenues, on non-IFRS basis, were €6.01 billion ($7.15 billion), up 4% year over year (up 10% at constant currency), better than the Zacks Consensus Estimate of $7.
SAP VRNT SAPGF SAVE DTEGF ADBE DTEGY
Investors seeking strong returns may allocate their assets in stocks with significant liquidity. Liquidity is an important yardstick that indicates a company’s capability to meet debt obligations by converting assets into cash. A company with a favorable liquidity position has the potential to generate higher returns as liquidity drives growth. However, one should exercise caution before investing in such stocks.
COP MLNX MCHP ADBE
So when Thyssenkrupp North America needed help predicting when to service its lifts, it turned to Microsoft Corp, a partnership that illustrates how Microsoft’s chief executive, Satya Nadella, has leveraged the cloud to grow its own business.
KR CVX MSFT SBUX ADBE
So when Thyssenkrupp North America needed help predicting when to service its lifts, it turned to Microsoft Corp , a partnership that illustrates how Microsoft's chief executive, Satya Nadella, has leveraged the cloud to grow its own business.
KR CVX MSFT SBUX ADBE
So when Thyssenkrupp North America needed help predicting when to service its lifts, it turned to Microsoft Corp (MSFT.O), a partnership that illustrates how Microsoft’s chief executive, Satya Nadella, has leveraged the cloud to grow its own business.
KR CVX MSFT SBUX ADBE
For those looking to find strong Computer and Technology stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Adobe Systems (ADBE - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to ADBE / Adobe Systems, Inc. on message board site Silicon Investor.
|Adobe (adbe) opinions||Adobe, Intel(MMX) and Windows Market|
|Adobe is it ready to move up?|
as of ET